Navigation Links
ADVENTRX Settles Dispute With Former Licensee
Date:6/30/2008

SAN DIEGO, June 30 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) today announced that it settled its dispute with Theragenex, LLC and its Chairman and President and Chief Executive Officer for payments aggregating $600,000, which payments the Company has received in full. The parties have agreed to jointly move to dismiss the underlying arbitration action and all related claims and counterclaims, with prejudice. In addition, in connection with dismissing the arbitration, the Company and Theragenex will release each other from any and all claims related to their past relationship.

In October 2007, the Company filed a demand for arbitration against Theragenex (doing business as TRx Pharma, LLC and/or TRx Pharmaceuticals, LLC) and its founder, Chairman and President and Chief Executive Officer in his individual capacity as the alter ego of Theragenex, seeking damages of up to $10 million with respect to breach of a license agreement, dated October 20, 2006, between the Company and Theragenex. In November 2007, Theragenex responded to the Company's demand, asserting numerous affirmative defenses, counterclaiming intentional misrepresentation, negligent misrepresentation and rescission and seeking a refund of its initial $500,000 payment under the license agreement, plus interest, rescission of the license agreement and that the Company pay its reasonable attorneys' fees and costs associated with the action.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease. The Company seeks to improve the performance and commercial po
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
2. ADVENTRX Appoints Vice President of Manufacturing
3. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
4. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
5. ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
6. Eric K. Rowinsky Joins ADVENTRX Board of Directors
7. ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 American Association for Cancer Research Annual Meeting
8. ADVENTRX Announces Consolidation of Clinical and Management Positions
9. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
10. ADVENTRX Appoints Vice President of Commercialization
11. ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... About Bioactive Material Bioactive ... are increasingly becoming popular due to their ability ... having a negative impact on the human health. ... tissue repair materials in surgical procedures. Bioactive materials ... glass-ceramics, and composites. The major end-users of bioactive ...
(Date:9/23/2014)... France (PRWEB) September 23, 2014 ... of laboratory personnel since 1968 and Burdinola, supplier of ... of a new filtered fume hood. , ... laboratory fume hood, Burdinola will now offer an innovative ... a wide range of chemicals, best-in-class detection technology, and ...
(Date:9/23/2014)... ATCC, the premier global biological materials resource and ... to the senior leadership team. Barbie Bigelow has joined ... and Dr. Maryellen de Mars also joins as the ... are new positions at ATCC. , ... described the additions as part of a revitalization strategy ...
(Date:9/23/2014)... September 23, 2014 Follow ... gaining steady popularity the world over, due to ... Growth in the marketplace is expected to come ... in developing countries. Several sub-Saharan countries in the ... have already implemented genetically engineered crop production strategies. ...
Breaking Biology Technology:Global Bioactive Material Market 2014-2018 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
... chemical reaction that causes iron to rust plays a similarly ... healthy cells and is a process, scientists know, that contributes ... from Alzheimer,s, heart disease and stroke to cancer and the ... edition (Feb. 21, 2008) of the journal Nature, a team ...
... ... Accuracy, PITTSBURGH, Feb. 20 Applied Isotope Technologies,("AIT") ... edition of the Federal Register as a part of the methods,section of ... Recovery Act). This updated version of the method includes,a long list of ...
... TAMPA, Fla., Feb. 20 Sirion Therapeutics, ... that it has entered into an exclusive ... FL for the worldwide rights to develop ... anti- inflammatory agent norketotifen., (Logo: ...
Cached Biology Technology:Genetic pathway critical to disease, aging found 2Genetic pathway critical to disease, aging found 3Newly Published EPA RCRA Method 6800 Supports AIT Technology 2Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases 2
(Date:9/23/2014)... have encountered variants or isoforms in microRNAs (miRNAs) before, ... recent study, published in the journal Oncotarget ... abundances that depend on geographic subpopulations and gender and ... may not be the one typically listed in the ... are much more common than we had previously assumed. ...
(Date:9/23/2014)... When the body forms new tissues during ... communicate with each other. For years, scientists believed ... researchers at Carnegie Mellon University and the University ... mechanical communication is equally if not more ... of the Proceedings of the National Academy ...
(Date:9/23/2014)... are fighting a cyberwar against cancer finds that the ... , "Recent research has found that cancer is already ... we studied the interplay between cancer and the immune ... on cancer," said Rice University,s Eshel Ben-Jacob, co-author of ... of the Proceedings of the National Academy of ...
Breaking Biology News(10 mins):Slight alterations in microRNA sequences hold more information than previously thought 2Slight alterations in microRNA sequences hold more information than previously thought 3The mechanics of tissue growth 2Immune system is key ally in cyberwar against cancer 2Immune system is key ally in cyberwar against cancer 3
... microscopic organ-on-a-chip devices that mimic the way real organs ... effects of therapies more accurately, will be discussed by ... week. Professor Don Ingber, Director of the ... will deliver the inaugural Bagrit Lecture, which will be ...
... Nitrogen pollution in our coastal ecosystems, the result of ... sewage, leads to decreased water transparency, the loss of ... speciessuch as the algae behind the renowned "red tides" ... pronounced in the Gulf of Mexico and the Caribbean. ...
... could a colorblind animal know how to change its ... will the animal,s predator "see," looking at its prey ... are addressed in article published today by a collaborative ... Hole, Mass., and the U.S. Military Academy in West ...
Cached Biology News:Media invitation: Pioneer of organ-on-a-chip technology to speak at Imperial College London 2Sewage-derived nitrogen increasingly polluting Caribbean ecosystems 2How can a colorblind animal change its colors to blend into the background? 2How can a colorblind animal change its colors to blend into the background? 3
... a partial recombinant IFNA2. Immunogen: ... is produced in E. coli. The biological ... OMIM: 147562, ... MM951100564 MA Code: ABV0P9DPB ...
Mouse monoclonal antibody raised against a partial recombinant STAU2. NCBI Entrez Gene ID = STAU2...
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
Mouse monoclonal antibody raised against a full length recombinant YARS. NCBI Entrez Gene ID = YARS...
Biology Products: